For Healthcare Professionals

For US residents only

Support & Resources for Galafold® (migalastat)

Rebecca, an actual Galafold patient.

Here to help.

Learn about Amicus Assist™, individualized financial support, check out the Galafold MyDay app, explore different organizations that support the Fabry community, and download printable materials.

For those prescribed Galafold, Amicus Assist™ is a call 1-833-AMICUS-A (1-833-264-2872) or click away.

Amicus Assist™ is a service designed to provide product assistance and support for Galafold.* As part of the program, you’ll be assigned a dedicated case manager.

Financial support

We are committed to helping you get access to Galafold. For example, your case manager can:

Verify and explain your insurance coverage

Identify possible sources of financial assistance.

Amicus Assist™ is dedicated to help identify possible sources of financial assistance including:

  • Co-Pay Assistance*: Eligible, commercially insured patients may pay as little as $0 per month for Galafold
  • Patient Assistance Program for eligible, uninsured or underinsured patients†
  • Support from independent charitable foundations: Amicus Assist™ can help identify independent charitable foundations who may be able to provide support. These foundations exist independently of Amicus and have their own eligibility criteria and application processes. Availability of support from the foundations is determined solely by the foundations.

Co-pay assistance is only available for patients with commercial (private) prescription drug insurance. Patients are not eligible for co-pay assistance if they are enrolled in a state or federally-funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, VA, DOD, or a state prescription drug assistance program or where prohibited by law. Offer is subject to program maximum limits. Offer is only available for U.S. residents who have a valid prescription for an Amicus product. Amicus reserves the right to rescind, revoke, or amend this offer without notice.

The Patient Assistance Program provides free product to those who qualify. Contact Amicus Assist for details.

Amicus makes no representation or guarantee concerning reimbursement or coverage for any service or item. Information provided through the Amicus Assist program does not constitute medical advice and is not intended to be a substitute for a consultation with a licensed healthcare provider or applicable third-party payer(s). Amicus reserves the right to modify the program at any time without notice.

Individuals must be prescribed Galafold for an approved indication to be eligible for support from Amicus Assist.

For all questions concerning insurance, including those on the prior-authorization process, please contact your case manager anytime Monday-Friday, 8AM-8PM ET.

Get assistance

Galafold MyDay

We all need a little help remembering things from time to time. That’s why we designed the Galafold MyDay app, to help you keep track of your Galafold routine.

Download today to get reminders:

  • Before and after you take Galafold (to inform you when to begin and end fasting)
  • Every other day to let you know when it’s a Galafold day
  • When it’s time for a prescription refill

Download today to get reminders:

  • Before and after you take Galafold (to inform you when to begin and end fasting)
  • Every other day to let you know when it’s a Galafold day
  • When it’s time for a prescription refill

Search for Galafold MyDay:

Available on the App Store

Apple, the Apple logo, and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries and regions. App Store is a service mark of Apple Inc.

Helpful links

Patient Advocacy Organizations

FSIG: Fabry Support & Information Group

Visit site

NORD: National Organization for Rare Disorders

Visit site

National Fabry Disease Foundation

Visit site

Global Genes: Allies in Rare Disease

Visit site

Genetic Alliance

Visit site

Everylife Foundation

Visit site

Rare Disease Legislative Advocates

Visit site

Fabry International Network

Visit site

Educational Tools

An Amicus-sponsored site to meet others living with Fabry disease and to watch videos on how Fabry works.

Fabry Connect

Connect with a genetic expert and take the quiz that can match your symptoms with genetic diseases.

Think Genetic

Materials made for printing and sharing.

Galafold Patient Brochure

Download En español

Galafold How-to-Take Brochure

Download En español

NEXT UP: Get Updates

INDICATION AND IMPORTANT SAFETY INFORMATION

Before taking Galafold® (migalastat), tell your healthcare provider about all of your medical conditions, including if you:

  • have kidney problems.
  • are pregnant or plan to become pregnant. It is not known if Galafold will harm your unborn baby.
  • have kidney problems.
  • are pregnant or plan to become pregnant. It is not known if Galafold will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. Galafold may pass into breast milk. Talk to your healthcare provider
    about the best way to feed your baby if you take Galafold.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of Galafold?

The most common side effects of Galafold include headache, stuffy or runny nose and sore throat, urinary tract infection, nausea, and fever.

These are not all the possible side effects of Galafold. Call your healthcare provider for medical advice about side effects.

What is Galafold?

Galafold is a prescription medicine used to treat adults with Fabry disease who have a certain genetic change (variant) in the galactosidase alpha gene (GLA) that is responsive (amenable) to Galafold.

It is not known if Galafold is safe and effective in children.

You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Amicus Therapeutics at 1-877-4AMICUS.

Please click here for Full Prescribing Information, including Patient Information and Instructions for Use.

js.